These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 825745)

  • 41. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 42. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 43. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Analgesic effects of tiapride in man. A double-blind comparative clinical trial against placebo (author's transl)].
    Clavel M; Pommatau E
    Sem Hop; 1980 Mar 8-15; 56(9-10):430-3. PubMed ID: 6244661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
    Otomo E; Araki G; Mori A; Kurihara M
    Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A double-blind comparison of a sulfurated mucopolysaccharide and placebo in the treatment of elderly patients with cerebrovascular insufficiency].
    Astengo F; Fontana L; Balestreri R
    Clin Ter; 1987 Feb; 120(3):219-26. PubMed ID: 2461828
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical double blind study with the calcium antagonist flunarizine cerebral circulatory disturbances].
    Eckmann F
    Arzneimittelforschung; 1985; 35(8):1276-9. PubMed ID: 3907638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J; Durocher AM; Lagrange M
    Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of Ginkgo biloba extract on neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double-blind study against placebo].
    Hofferberth B
    Arzneimittelforschung; 1989 Aug; 39(8):918-22. PubMed ID: 2684175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of cerebral circulatory insufficiency. Double-blind study of the efficacy of a quinine-papaverine combination].
    Klemm J
    Fortschr Med; 1984 Oct; 102(39):1000-2. PubMed ID: 6389288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 53. [Contribution of psychometry of clinical evaluation of the therapeutic effect of "Solcoseryl" in states of intellectual weakness connected with chronic cerebral circulatory insufficiency (author's transl)].
    Brasseur R; Lagesse Ch
    Schweiz Rundsch Med Prax; 1977 Mar; 66(10):312-7. PubMed ID: 322116
    [No Abstract]   [Full Text] [Related]  

  • 54. The objective measurement of mental performance in cerebrovascular disease. A double-blind controlled study, using a graded-release preparation of isoxsuprine.
    Hussain SM; Gedye JL; Naylor R; Brown AL
    Practitioner; 1976 Feb; 216(1292):222-8. PubMed ID: 772660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of trophic ulcers of the lower extremities with Trental-400].
    Koshkin VM; Bogdanets LI; Makarova LD
    Khirurgiia (Mosk); 1996; (1):49-51. PubMed ID: 8683922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Asa foetida in the treatment of the irritable colon: a double-blind trial (author's transl)].
    Rahlfs VW; Mössinger P
    Dtsch Med Wochenschr; 1979 Jan; 104(4):140-3. PubMed ID: 365493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 60. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
    Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
    Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.